Pharma: Other News To Note
Wednesday, October 10, 2012
Foundation Medicine Inc., of Cambridge, Mass., signed a multiyear agreement with Eisai Co. Ltd., of Tokyo, for genomic profiling and diagnostic discovery in a multisite, international clinical trial testing an Eisai therapeutic candidate.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.